Literature DB >> 11864718

The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD).

Bertha K Madras1, Gregory M Miller, Alan J Fischman.   

Abstract

The dopamine transporter is elevated in adults with attention deficit hyperactivity disorder (ADHD) compared with healthy controls [Lancet 354 (1999) 2132]. The findings have been confirmed by others in a different population using a different probe for the dopamine transporter. Notwithstanding the need to confirm these findings in a multi-center trial, several hypotheses are presented to account for these observations. A premise that elevated transporter levels result from medication is not supported by current data. Other possibilities, including hypertrophy of dopamine neuronal terminals in the striatum, dysfunctional regulation of dopamine or dopamine receptors, or anomalies in the dopamine transporter gene are presented as hypotheses. The feasibility of exploring these mechanisms in animal models or in human subjects is explored.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11864718     DOI: 10.1016/s0166-4328(01)00439-9

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  20 in total

1.  Whole-body biodistribution and radiation dosimetry estimates for the PET dopamine transporter probe 18F-FECNT in non-human primates.

Authors:  Dnyanesh N Tipre; Masahiro Fujita; Frederick T Chin; Nicholas Seneca; Douglas Vines; Jeih-San Liow; Victor W Pike; Robert B Innis
Journal:  Nucl Med Commun       Date:  2004-07       Impact factor: 1.690

2.  Genetic associations between ADHD and dopaminergic genes (DAT1 and DRD4) VNTRs in Korean children.

Authors:  Jun Ho Hong; In Wook Hwang; Myung Ho Lim; Ho Jang Kwon; Han Jun Jin
Journal:  Genes Genomics       Date:  2018-08-11       Impact factor: 1.839

3.  The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration.

Authors:  Jared W Young; Andrew K L Goey; Arpi Minassian; William Perry; Martin P Paulus; Mark A Geyer
Journal:  Pharmacol Biochem Behav       Date:  2010-04-02       Impact factor: 3.533

4.  Brief report: pervasive developmental disorder can evolve into ADHD: case illustrations.

Authors:  Deborah Fein; Pamela Dixon; Jennifer Paul; Harriet Levin
Journal:  J Autism Dev Disord       Date:  2005-08

5.  Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methylphenidate in a potential new rat model of attention deficit hyperactivity disorder.

Authors:  Katherine N Hewitt; Yasmene B Shah; Malcolm J W Prior; Peter G Morris; Chris P Hollis; Kevin C F Fone; Charles A Marsden
Journal:  Psychopharmacology (Berl)       Date:  2005-04-28       Impact factor: 4.530

6.  Adderall produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers.

Authors:  B Matthew Joyce; Paul E A Glaser; Greg A Gerhardt
Journal:  Psychopharmacology (Berl)       Date:  2006-10-10       Impact factor: 4.530

7.  Intracortical motor inhibition and facilitation in adults with attention deficit/hyperactivity disorder.

Authors:  Jacqueline Hoeppner; Martin Neumeyer; Roland Wandschneider; Sabine C Herpertz; Wolfgang Gierow; Frank Haessler; Johannes Buchmann
Journal:  J Neural Transm (Vienna)       Date:  2008-11-06       Impact factor: 3.575

8.  Hyperactivity following postnatal NMDA antagonist treatment: reversal by D-amphetamine.

Authors:  Anders Fredriksson; Trevor Archer
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

9.  Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane.

Authors:  Thomas J Spencer; Joseph Biederman; Bertha K Madras; Darin D Dougherty; Ali A Bonab; Elijahu Livni; Peter C Meltzer; Jessica Martin; Scott Rauch; Alan J Fischman
Journal:  Biol Psychiatry       Date:  2007-05-23       Impact factor: 13.382

10.  Family-based association study of the BDNF, COMT and serotonin transporter genes and DSM-IV bipolar-I disorder in children.

Authors:  Eric Mick; Janet Wozniak; Timothy E Wilens; Joseph Biederman; Stephen V Faraone
Journal:  BMC Psychiatry       Date:  2009-02-04       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.